rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Oculis Holding AG -

OCS · Nasdaq

Health CareBiotechnologyNot moving yet

OCS stood above a rising 150-day average in 31 of the last 52 weekly readings, and has been out of that trend for the last 21 weeks. It is 57.5% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 21
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
58 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders58+4 on the quarter
New · exited22 · 18
Reported value$316.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
EQT Fund Management S.a r.l.added · filed 13 Aug 20266,950,294$96.4M+1,050,000+17.8%
Aberdeen Group plcadded · filed 31 Jul 20262,159,809$30.0M+412,863+23.6%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 20262,042,467$28.3M+1,129,433+123.7%
Pivotal bioVenture Partners Investment Advisor LLCreduced · filed 13 Aug 20261,506,250$20.9M-174,033−10.4%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026987,204$13.7M+825,920+512.1%
BRAIDWELL LPnew · filed 14 Aug 2026834,183$11.6M+834,183
PERCEPTIVE ADVISORS LLCadded · filed 14 Aug 2026808,827$11.2M+315,000+63.8%
Saturn V Capital Management LPadded · filed 14 Aug 2026684,880$9.5M+168,119+32.5%
SR One Capital Management, LPunchanged · filed 12 Aug 2026641,022$8.9M00.0%
Siren, L.L.C.new · filed 13 Aug 2026625,000$8.7M+625,000
31 Mar 2023 – 30 Jun 2026
83256Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.